EPISODE · Sep 4, 2019 · 14 MIN
Cancer Topics - ASCO Guidelines: Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline
from ASCO Education
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health on the guideline update. This update adds anastrozole to the options of pharmacologic interventions for breast cancer risk reduction based on recent practice changing data. Read the full guideline at www.asco.org/breast-cancer-guidelines.
Embed this episode
NOW PLAYING
Cancer Topics - ASCO Guidelines: Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline
0:00
14:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of ASCO Education?
This episode is 14 minutes long.
When was this ASCO Education episode published?
This episode was published on September 4, 2019.
Can I download this ASCO Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!